HYO JIN LEE

Professor

Chungbuk National University

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Cancer Biology Cancer Biology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Hyo Jin Lee is a faculty member at Chungnam National University in South Korea. His research focuses on innovative cancer therapies, including the engineering of bacterial systems for tumor imaging and treatment, as well as the efficacy of various immunotherapeutic strategies. Recent publications highlight his work on interleukin-21 secreting Salmonella, the role of GDF15 in gallbladder cancer progression, and subgroup analyses of immunotherapy trials in Asian populations.

Articles (26)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (11)

Ji Youl Lee

SOUTH KOREA

View details

Ik-Chan Song

Chungbuk National University

SOUTH KOREA

View details

Jeong Eun Lee

Prof.

Chungbuk National University

SOUTH KOREA

View details

Daejin lim

Kangnam University

SOUTH KOREA

View details

Heung Jin Jeon

Chonnam National University

SOUTH KOREA

View details

Kwonoh Park

Professor

Pusan National University Yangsan Hospital

SOUTH KOREA

View details

Jung-Hyun Lee

Professor

Korea University

SOUTH KOREA

View details

Kyung Sook Shin

Seoul National University Hospital

SOUTH KOREA

View details

Deog-Yeon Jo

Chungnam National University School of Medicine

SOUTH KOREA

View details

Dong Ha Kim

Prof.

Ewha Womans University

SOUTH KOREA

View details

Jae Lyun Lee

University of Ulsan College of Medicine

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

HYO JIN LEE

Research Interests

Explore related searches

Contact this professor

About

Articles (26)

Engineering Bacterial Secretion Systems for Enhanced Tumor Imaging and Surgical Guidance

Attenuated Salmonella secreting interleukin-21 activates T-cells and induces anti-tumor effects

Tumour-specific delivery of ω-conotoxin MVIIA via engineered Salmonella for safe anticancer therapy

Nivolumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4)

GDF15 promotes gallbladder cancer progression by activating the NF-kB mediated Vascular Endothelial Growth Factor A (VEGFA) expression

First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia

A Multicenter Phase II Study of Modified FOLFIRINOX for First-line Treatment for Advanced Urachal Cancer (ULTMA; KCSG GU20-03)

Outcomes by Retrospective Eligibility for Maintenance Therapy of Patients With Advanced Urothelial Carcinoma: Post Hoc Analysis of the Phase 3 KEYNOTE-361 Trial

Post-transplant cyclophosphamide plus anti-thymocyte globulin decreased serum IL-6 levels when compared with post-transplant cyclophosphamide alone after haploidentical hematopoietic stem cell transplantation

Controlling tumor progression and recurrence in mice through combined treatment with a PD-L1 inhibitor and a designer Salmonella strain that delivers GM-CSF

Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)

Effectiveness of Adding Docetaxel to Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer in Korean Real-World Practice

Efficacy of cisplatin combined with vinorelbine as second- or higher-line palliative chemotherapy in patients with advanced ovarian cancer

Hederacolchiside A1 Suppresses Autophagy by Inhibiting Cathepsin C and Reduces the Growth of Colon Cancer

GDF15 Promotes Cell Growth, Migration, and Invasion in Gastric Cancer by Inducing STAT3 Activation

The Frontline Immunotherapy-Based Treatment of Advanced Clear Cell Renal Cell Carcinoma: Current Evidence and Clinical Perspective

Volumetric Splenomegaly in Patients With Polycythemia Vera

Loss of Von Hippel–Lindau (VHL) Tumor Suppressor Gene Function: VHL–HIF Pathway and Advances in Treatments for Metastatic Renal Cell Carcinoma (RCC)

Perioperative Systemic Treatment for Muscle-Invasive Bladder Cancer: Current Evidence and Future Perspectives

MITF Promotes Cell Growth, Migration and Invasion in Clear Cell Renal Cell Carcinoma by Activating the RhoA/YAP Signal Pathway

Dsg2-mediated c-Met activation in anaplastic thyroid cancer motility and invasion

A comparison of post-transplantation cyclophosphamide versus antithymocyte-globulin in patients with hematological malignancies undergoing HLA-matched unrelated donor transplantation

Efficacy of cisplatin combined with topotecan in patients with advanced or recurrent ovarian cancer as second- or higher-line palliative chemotherapy

Efficacy of cisplatin combined with topotecan in patients with advanced or recurrent ovarian cancer as second- or higher-line palliative chemotherapy

Adrenal insufficiency due to recurrent renal cell carcinoma in the left adrenal gland 3 years after right radical nephrectomy for renal cell carcinoma

Alteration of CYP4A11 expression in renal cell carcinoma: Diagnostic and prognostic implications

Collaborators (11)

Ji Youl Lee

Ik-Chan Song

Jeong Eun Lee

Daejin lim

Heung Jin Jeon

Kwonoh Park

Jung-Hyun Lee

Kyung Sook Shin

Deog-Yeon Jo

Dong Ha Kim

Jae Lyun Lee

Make your next move.